 Home > Active Ingredient News > Drugs Articles > Novavax: New crown vaccine sales plummeted 90%, stock price fell 34%

Novavax: New crown vaccine sales plummeted 90%, stock price fell 34%

 Last Update: 2022-08-15
 Source: Internet
 Author: User

Tags

united states electricity

recombinant influenza vaccine

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

On August 8, 2022, Novavax released its second-quarter financial report, with an operating income of US$186 million, of which the sales of the new crown recombinant protein vaccine NVX-CoV2373 was US$55 million, the cost of sales was US$271 million, and the R&D investment was US$290 milli.

In the first quarter of this year, sales of NVX-CoV2373 were US$705 million, and sales in the second quarter plummeted by 90% compared to the first quart.

Affected by this news, Novavax's stock price fell 34% after the market, and the current market value is only 3 billion US dolla.

NVX-CoV2373 is a trimeric full-length S protein vaccine with Matrix-M adjuva.

Summarize

The huge market opportunity brought by the new crown vaccine, but the competition is fierce and the window of opportunity is actually sma.

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

Best price Pure Tirzepatide powder 10mg vial Tirzepatide CAS 2023788-19-2 ouda

CAS No.: 2023788-19-2

Pharmacy Grade

$40.00/G FOB

Safe Delivery Freeze Dried Peptides Raw Powder Weight Loss Tirze Peptide Sema 5mg 10mg

CAS No.: 2023788-19-2

Pharmacy Grade

$120.00/UNIT FOB

RU 58841 CAS 154992-24-2 RU58841 Powder Bulk RU-58841 For Hair Growth and Anti Hair Loss

CAS No.: 154992-24-2

Pharmacy Grade

$1-1.2/KG FOB

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.